A AB BS S T TR RA AC CT T Point mutations in the Wolfram syndrome 1 gene (WFS1) are attributed the autosomal dominant and/or recessive mild type sensorineural hearing loss in first degree relatives. Total genomic DNA was isolated from peripheral blood of affected probands and controls. Multiplex polymerase chain reaction was performed and followed by multiplex ligated probe amplification analysis. Sensorineural hearing loss was moderate in a 48-year-old male patient (case 1) and sensorineural hearing loss and optic atrophy were evident in his 16 year old daughter (case 2). We identified heterozygous deletion in exon 8 of WFS1 gene (Wolframin protein) in father and in one of his affected daughters with hearing loss and optic atrophy. The genetic results demonstrate the necessity of screening for the possible point mutation and/or larger deletions in WFS1 gene in cases with non-syndromic mild type sensorineural hearing loss. This study emphasizes the need for careful molecular evaluation in cases with impaired hearing, insulin-dependent diabetes mellitus and optic atrophy for the diagnosis of Wolfram syndrome. Proper genetic counseling must be given accordingly to patients and their other family members since it is important for their next generation. 
Heterozygous Deletion of Exon 8 in WFS1 Gene in Two Wolfram Syndrome Probands with Hearing Loss: Case Report A AB BS S T TR RA AC CT T Point mutations in the Wolfram syndrome 1 gene (WFS1) are attributed the autosomal dominant and/or recessive mild type sensorineural hearing loss in first degree relatives. Total genomic DNA was isolated from peripheral blood of affected probands and controls. Multiplex polymerase chain reaction was performed and followed by multiplex ligated probe amplification analysis. Sensorineural hearing loss was moderate in a 48-year-old male patient (case 1) and sensorineural hearing loss and optic atrophy were evident in his 16 year old daughter (case 2). We identified heterozygous deletion in exon 8 of WFS1 gene (Wolframin protein) in father and in one of his affected daughters with hearing loss and optic atrophy. The genetic results demonstrate the necessity of screening for the possible point mutation and/or larger deletions in WFS1 gene in cases with non-syndromic mild type sensorineural hearing loss. This study emphasizes the need for careful molecular evaluation in cases with impaired hearing, insulin-dependent diabetes mellitus and optic atrophy for the diagnosis of Wolfram syndrome. Proper genetic counseling must be given accordingly to patients and their other family members since it is important for their next generation. Altuntaş ve ark. Tıbbi Genetik e a ring loss is the most com mon sen so ri neu ral di sor der that pre sent in one of every 1000 new borns. He a ring im pa ir ment can be clas si fi ed as mild, mo de ra te, or se ve re, inc lu ding to tal de af ness. Dysfunc ti on or de ge ne ra ti on of elements such as coch le a, ne u rons, stri a vas cu la ris and ne u ral net work alo ne, or in com bi na ti on, can result in coch le ar im pa ir ment and sen so ri ne u ral hea ring loss in hu mans. Sen so ri ne u ral he a ring loss not only in vol ves a re duc ti on in so und le vel or abi lity to he ar fa int so unds, but al so af fects spe ech unders tan ding, or abi lity to he ar cle arly. Birth in jury, vi ru ses, he ad tra u ma, au to to xic me di cations, ge netic syndro mes, aging and tu mors may ca u se this type of he a ring loss. 1 Ap pro xi ma tely 0.1% of children are born with pro fo und he a ring loss in many po pu la ti ons. The di sor der DFNB1 (De af ness, Ne uro sen sory, au to so mal re ces si ve 1) is ca u sed by defects of the con ne xin 31 pro te in that is co ded by GJB2-6 ge ne which is lo ca ted on chro mo so me 1p 35.1 re gi on. Mo re than 100 mu ta ti ons in GJB2 ge ne have be en des cri bed in ge ne tic de af ness. The de fects of WFS1 ge ne which is lo ca ted on chro mo so me 4p 16 .1 and en co des the wol fra min DFNA pro te in cau se the syndro mic he a ring im pa ir ment. The pre valan ce of Wol fram syndro me (WFS) is one in 770 000 li ve births, with car ri er fre qu ency of one in 354. 2 WFS is an un com mon prog res si ve ne u ro dege ne ra ti ve di sor der cha rac te ri zed by di a be tes in sipi dus, di a be tes mel li tus, op tic at rophy and de af ness with an au to so mal re ces si ve pat tern of in he ri tance. [3] [4] [5] Alt ho ugh so me stu di es ha ve pro vi ded eviden ce for ge ne tic he te ro ge ne ity, the ge noty pe-phe noty pe re la ti ons are not cle ar. Pa tients are pro ne to de ve lop di a be tes in si pi dus, de afness, and uri nary tract and ne u ro lo gi cal ab nor ma li ti es. Ap pro xi ma tely 60% of pa ti ents with WFS di e at age 35, usu ally du e to cen tral res pi ratory cen ter fa i lu re fol lo wing bra in stem at rophy. 6, 7 Ei berg et al. 8 re por ted a ca se of au to so mal do minant op tic at rophy with he a ring im pa ir ment and im pa i red glu co se re gu la ti on which is as so ci a ted with a mis sen se mu ta ti on in the WFS1 ge ne.
K
Cur rent study ai med to find out the pos sib le ro le of the mu ta ti ons in the GJB2-6 and WFS1 genes with MLPA tech ni qu e in two first deg re e re lati ve pro bands with non-syndro mic sen so ri ne u ral he a ring im pa ir ment and mild type op tic at rophy. Anot her aim of the cur rent study was to in ves ti gate the fa mily mem bers of pa ti ents with mild sensorineural hearing loss for pos sib le po int mu ta ti ons in WSF1 ge ne re gi on for early cli ni cal di ag no sis and ge ne tic co un se ling and to put for ward the importance of genetic counseling.
AU DI O LO GIC EVA LU A TI ON PRO TO COL
We eva lu a ted two Tur kish pa ti ents with WS from the sa me fa mily: Fat her (ca se 1) who had di a be tes mel li tus, he a ring im pa ir ment and op tic at rophy and his two da ugh ters, one of them (ca se 2) had a uni la te ral sen so ri ne u ral he a ring loss in her left ear. Genetic analysis was performed, en doc ri no lo gic pa ra me ters were tested and ul tra so nog raphy, threshold to nal au di o metry and pu re to ne au di o met ric analy sis (In te ra cus ti cus AC40) were performed and so me ot her cli ni cal pa ra me ters were investigated in the cur rent pro bands. The he a ring in volve ment was mo ni to red by suc ces si ve au di o met ric exa mi na ti ons: on the day of pre sen ta ti on, and every two days af ter pre sen ta ti on.
He a ring was classified as nor mal, con duc ti ve hearing loss, mi xed hearing loss and sen so ri ne u ral hearing loss ac cor ding to San tos & Rus so. 9 The pure to ne ave ra ge of 500, 1000, 2000, and 4000 Hz was calculated. Clas si fi ca ti on of the deg re e of he aring loss was al so es tab lis hed ac cor ding to the thres hold, as re com men ded by Sha mes and Wiing: 10 <15dBHL nor mal; 16-40 dBHL slight; 41-55 dBHL mild; 56-70 dBHL mo de ra te; 71-90dBHL seve re; >91 dBHL pro fo und hearing loss. 10 
CA SE 1
A 43-ye ar-old man presented with an eight year history of prog res si ve he a ring loss and tin ni tus in his left ear started 10-20 days ago. Ear, no se and thro at exa mi na ti on re ve a led tympa nosc le ro sis on the right ear drum of the pa ti ent. His per so nal history inc lu ded an ope ra ti on on the right ear (simple mas to i dec tomy and tympa nop lasty) that was per for med in anot her ins ti tu ti on two ye ars ago. The he a ring loss was de ter mi ned with pu re to ne au di o metry. The au di o met ric re sults sho wed the mild mi xed type he a ring loss in the right ear, acous tic tra u ma (sen so ri ne u ral he a ring loss after 2000 Hz) and mild sen so ri ne u ral he a ring loss in the left ear (Fi gu re 1a). He a ring im pa ir ment in the right ear was prog res si ve and ob vi o usly de tec tab le with the au di o metry. Pa ti ent was at risk for de ve lo ping in su li n de pen dent di a be tes mel li tus. His blo od gluco se le vels we re me a su red and they tur ned to be wit hin the nor mal li mits (fas ting blo od glu co se level is 94 mg/dl, postpran di al blo od glu co se le vel is 104 mg/dl.) af ter in su li n tre at ment.
Pa ti ent was treated with 2 ml on ce a day vi tami ne B (B1, B6, B12, fo lic acid, ni co ti na mi de and cal ci um pan tot he na te) com bi na ti on; vi ta mi ne C, 1 ml on ce a day; Gink go glycosi de 100 mg, fo ur times a day and de xa met ha so ne 40 mg on ce a day, for thre e days.
CA SE 2
The se cond ca se was a 16-ye ar-old girl, the da ughter of the ca se 1 (Fi gu re 1b) who sho wed sen so rine u ral he a ring loss and op tic at rophy. She had comp la i ned of he a ring loss for one ye ar. . Sen so rine u ral mild he a ring loss and he a ring im pa ir ment we re de tec ted in her left ear (Fi gu re 1b). Her right ear was with pu re to ne au di o metry. She was analyzed for the si mi lar cli ni cal fin dings and in ves ti gated for the pos sib le mu ta ti ons in GJB2-6 and WFS1 ge ne re gi ons by MLPA tech ni qu e, li ke ca se 1. He te rozy go us de le ted mu ta ti on was de tec ted in exon 8 of WSF1 ge ne in both ca ses (Fi gu re 2, ar rows). No mu ta ti on was de tec ted in ot her ge ne spam that exa mi ned (con ne xin 21, 26 and 30; Fi gu re 2). Ear, nose and thro at exa mi na ti on was nor mal. Blo od 
FIGURE 2:
Detection of WFS1 gene exon 8 deletion in normal control and affected cases with MLPA method. Capillary electropherograms are from a normal control (top) and father with sensorineural hearing impairment (case 1) and one of his affected doughter (case 2). The apparent heterozygous deletion with ~50% peak reduction in WFS1 exon 8 gene region was indicated in both affected cases with sensorineural hearing impairment (red arrows).
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Altuntaş ve ark.
Tıbbi Genetik glu co se le vels of this pa ti ent we re wit hin the normal li mits.
Both ca ses we re fol lo wed cli ni cally for two ye ars and au di o met ric me a su re ments in di ca ted prog res si ve he a ring loss in both patients. Oph thalmo lo gic exa mi na ti on inc lu ded the best cor rec ted vi su al acu ity de ter mi na ti on, fun dus copy, flu o resce in re ti nal an gi og raphy, and Gold mann ki ne tic pe ri metry.
Pa ti ents' pe dig re e analy sis sho wed do mi nantly in he ri ted sen so ri ne u ral he a ring loss. Fat her (ca se 1, II-4) and his both da ugh ters (ca se 2-ar row, II I-1 and 2) we re in ves ti ga ted for mu ta ti on in GJB2-6 and WFS1 ge ne re gi ons by MLPA tech ni qu e. Ot her fa mily mem bers that we re in di ca ted with a qu es tion mark in the pe dig re e (I-1, II-3 and 6) we re known as the in di vi du als with sen so ri ne u ral he aring loss but were not in ves ti ga ted with ge ne tic analy sis. The pe dig re e shows the do mi nant type of sen so ri ne u ral he a ring loss tra it in the cur rent fa mily pro fi le thro ugh thre e ge ne ra ti ons (Fi gu re 3).
DNA ISO LA TI ON AND MU TA TI ON ANALY SIS
To tal ge no mic DNA was ex trac ted from the 200 µl phe rip he ric blo od samp les with the In vi tek blo od (250) DNA iso la ti on pro ce du re (In vi tek, Ger many). The mu ta ti on analy sis of GJB3 exons 1-3 and WFS1 exons 1 and 8 ge nes we re per for med with mul tip lex polymerase chain reaction (PCR) amp li fi ca ti on tech ni qu e. The mul tip lex li ga ted probe amp li fi ca tion (MLPA) pro ducts of tar get ge nes we re ge notyped by ca pil lary elec trop ho re sis of MLPA tech ni qu e ac cor ding to the ma nu fac tu rer's ins truc ti ons.
All 11 exons of the GJB3 and WFS1 ge nes were amp li fi ed. Bri efly, 150 ng DNA was de na tu red and hybri di zed over night at 60 °C with SAL SA probe mix. Af ter tre a ting the samp les with li ga se 65 for 15 min at 54 °C, PCR was per for med with the spe ci fic SAL SA FAM PCR pri mers. Ca pil lary electrop ho re sis of PCR pro ducts was per for med using an ABI PRISM 310 and da ta analy sis was per formed by ex por ting the pe ak are as to a Ge ne Map per (AB) and Cof faly zer V8 (MRC, Net her lands). Each re sult from ca ses and con trol we re con fir med by two in de pen dent tests. A he te rozy go us de le ti on was de tec ted in fat her and his af fec ted da ugh ter with non-syndro mic he a ring loss (Fi gu re 2, Ca se 1 and 2). Mu ta ti on scre e ning re ve a led the he te rozygo us dis tinct va ri ants in WFS1 ge ne of exon 8. Pheno me non was sho wed au to so mal in he ri tan ce of Wol fram Syndro me in both ca ses. No mu ta ti on was de tec ted in ot her non-af fec ted da ugh ter.
The pre sent study was ap pro ved by lo cal ethics com mit te e and a writ ten in for med con sent was ob ta i ned from all ca ses.
DISCUSSION
He a ring loss is one of the most com mon in he ri ted dis sor ders and up to 50% of the cases with au to somal re ces si ve non-syndro mic sen so ri ne u ral he a ring loss are as so ci a ted with a mu ta ti on in the lo cus DFNB. DFNB con ta ins two con ne xin ge nes namely GJB2 and GJB6. Wol fram syndro me is an au to somal re ces si ve di sor der with se ve re ne u rode ge ne rati on. Af fec ted in di vi du als pre sent with ju ve ni leon set in su lin-de pen dent di a be tes mel li tus, op ti c atrophy, di a be tes in si pi dus, sen so ri ne u ral de af ness, de men ti a, psychi at ric ill nes ses, re nal-tract ab norma li ti es and blad der atony. In ad di ti on, do mi nant mu ta ti ons in the WFS1 ge ne ha ve be en shown to play a ro le in low-fre qu ency sen so ri ne u ral he a ring loss, prog res si ve he a ring loss, and de af ness with opti c at rophy. Cx mu ta ti ons are now wi dely ac cep ted as one of the most com mon hu man mu ta ti ons ca using se ve re sen so ri ne u ral de af ness.
11,12
FIGURE 3: Pedigree analysis shows the dominant inheritance type of sensorineural hearing loss in a current large family. The family members that were indicated with question mark (I-1, II-3 and 6) were reported as the patients with sensorineural hearing loss but not investigated with genetic analysis (Arrows indicate the proband cases).
Gas pa rin et al. 13 re por ted no vel mu ta ti ons in exon 8 of WFS1 ge ne in 27 Bra zi li an pa ti ents with WFS. Ho mozy go us and/or com po und he te rozy gous WFS1 mu ta ti ons we re re por ted in WFS in Leba non po pu la ti on.
14 Evir gen et al. 15 sho wed that 35delG mu ta ti on was the most fre qu ent one which led to con ge ni tal he a ring loss in Tur key. A wi de ran ge of ge ne mu ta ti ons such as PAX, Con ne xin 26 (GJB2), Con ne xin 30 (GJB6), Con ne xin 31 (GJB3), Wol fra min pro te in (DFNA) and SLC26A4 we re repor ted in pa ti ents with he a ring loss. [16] [17] [18] Da i et al. 17 sho wed SLC26A4 ge ne va ri a ti on in pa ti ents with sen so ri ne u ral he a ring loss in Chi ne se po pu la ti on. Mu ta ti ons in mi toc hon dri al DNA (mtDNA) are the ma jor ca u se of he a ring loss. Ba e et al. 16 per for med a syste ma tic mu ta ti o nal scre e ning of 12S rRNA, tRNA Ser (UCN), tRNA Lys and tRNA Le u (UUR) ge nes in 227 un re la ted pa ti ents with nonsy ndromic he a ring im pa ir ment in Ko re an po pu la ti on. On the ot her hand Le e et al. 19 re por ted that GJB2-6 and SLC26A4 mu ta ti ons to get her were the ma jor ca use of con ge ni tal he a ring loss in the Ko re an po pu lati on. In cur rent re port, no mu ta ti on was de tec ted in the GJB2-6 ge nes in both ca ses. Struc tu ral ge ne de le ti on in Con ne xin 30 (GJB6) is fre qu ently se en in Spa in, Fran ce, the Uni ted King dom, Is ra i l and Bra zil. No po int mu ta ti ons we re de tec ted in GJB ge nes (Con ne xin 26, 30 and 31) in the cur rent three fa mily mem bers with a non-sy ndro mic he a ring loss. Sa me re sults of wild type Con ne xin 30 ge ne pro fi les we re al so re por ted by Del Cas til lo et al. 20 in ca ses with non-sy ndro mic he a ring loss.
Prog res si ve he a ring im pa ir ment is a form of non-syndro mic, non-con ge ni tal sen so ri ne u ral hea ring loss, which has an au to so mal do mi nant tra it with va ri ab le age of on set and prog res si on ra tes. Phe noty pe/ge noty pe cor re la ti on is dif fi cult and the sa me mu ta ti on may re sult in dif fe rent in di vi du al phe noty pes. All types of dominantly inherited prog res si ve he a ring losses even tu ally prog ress to se vere or pro fo und he a ring loss, as in our cur rent ca se 1 (fat her). Asy mmet ric and mild to se ve re prog ressi ve sen so ri ne u ral he a ring loss was de tec ted in case 1 and an early-on set symmet ric he a ring loss was de tec ted in one of his af fec ted da ugh ters (ca se 2).
Ca se 1 and ca se 2 we re di ag no sed as WS du e to their cli ni cal fin dins of he a ring loss, in su li n de pen dent di a be tes mel li tus (only ca se 1), op tic at rophy and WSF1 ge ne mu ta ti on. Ca se 2 sho wed a less se ve re Wol fra me phe noty pe of op tic at rophy and uni la teral he a ring loss. Ge ne tic stu di es in pa ti ents with WS re por ted a wi de spectrum of mu ta tions in co ding se qu en ce of WSF1 ge ne. In our both ca ses, dele ted mu ta ti on was de tec ted in only one al le le (he te rozy go us) in exon 8 of WSF1 ge ne. The conne xin ge nes that exa mi ned we re in nor mal struc ture in both ca ses.
WFS1 mu ta ti ons at theDF NA6/14/38 lo cus we re first des cri bed in 2001 in six fa mi li es with low fre qu ency sen so ri ne u ral he a ring loss (LFSNHL) that was non-prog res si ve be low 2000 Hz; the ca usa ti ve mu ta ti ons all clus te red in the C-ter mi nal doma in of the wol fra min pro te in. 21 Au to so mal do mi nant LFSNHL ap pe ars highly pre dic ti ve of a WFS1 mu ta ti on, and ca u ses of LFSNHL inc lu de ret ro coch le ar le si ons and coch le ar otosc le ro sis. 22 Most pos sibly, the cur rent ca ses are the first re por ted examp les of an au to so mal do mi nant prog res si ve he a ring loss which is as so ci a ted with a he te rozy go us WFS1 exon 8 ge ne mu ta ti on. In this study, two members of the family with au to so mal do mi nant LFSNHL had mu ta ti ons in the WFS1 gene, in di ca ting a non-syndro mic low frequency hea ring loss. However, the na tu re of he a ring loss in ca se 1 was prog res si ve. He re we re com mend the syste ma tic analy sis of WFS1 ge ne se qu en ces in pati ents with pa ren tally in he ri ted di a be tes mel li tus and non-syndro mic de af ness. Our da ta al so sho wed that WFS1 exon 8 which en co des a pro te in with an ex ten ded C-ter mi nal do ma in is the ma jor ge ne invol ved in WS pro bands.
CONCLUSION
Ge ne tic mu ta ti ons are an im por tant ca u ses of hea ring loss. Two ca ses p re sen ted in this study and their ge ne tic re sults in di ca te that pos sib le po int mu a ta ti on and/or lar ger de le ti ons in WFS1 ge ne is as so ci a ted with au to so mal do mi nant nonsyndro mic mild type sen so ri ne u ral he a ring loss. Tech no lo gic de ve lop ments, new exa mi na ti on tech ni qu es, and ge ne tic tests ha ve al lo wed ear li er and mo re ac cu ra te di ag no sis, pro vi ding furt her cla ri fi ca ti on on the eti o logy of the con di ti on. In conc lu si on, fa mi li es which ha ve mo re than one ca se with cli ni cal fin digs of Wol fra me Syndro me must be sec re ened for tar get GJB2-6 and WSF1 genes and ap prop ri a te ge ne tic co un se ling must be performed. This study emp ha si zes the ne ed for a ca re ful mo le cu lar eva lu a ti on in ca ses with im pa ired he a ring, in su lin-de pen dent di a be tes mel li tus and op tic at rophy for the di ag no sis of Wol fram syndro me. Pro per ge ne tic co un se ling gi ven to pati ents and the ir fa mily mem bers is im por tant for their next ge ne ra ti on.
